Education
About Us
Working with TipRanks
Follow Us
BioVie (BIVI)
NASDAQ:BIVI
Total Valuation
BioVie has a market cap or net worth of $13.11M. The enterprise value is $1.75M.
Market Cap$13.11M
Enterprise Value$1.75M
Share Statistics
BioVie has 7,534,225 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,534,225
Owned by Insiders15.10%
Owned by Institutions0.39%
Financial Efficiency
BioVie’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -93.31%.
Return on Equity (ROE)-0.94
Return on Assets (ROA)-0.83
Return on Invested Capital (ROIC)-93.31%
Return on Capital Employed (ROCE)-0.94
Revenue Per Employee0.00
Profits Per Employee-1.25T
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioVie is ―. BioVie’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value<0.01
Price to FCF―
Price to Operating Cash Flow>-0.01
PEG Ratio―
Income Statement
In the last 12 months, BioVie had revenue of 0.00 and earned -17.91T in profits. Earnings per share was -12.12.
Revenue0.00
Gross Profit-229.38B
Operating Income-18.07T
Pretax Income-17.91T
Net Income-17.91T
EBITDA-18.07T
Earnings Per Share (EPS)-12.12
Cash Flow
In the last 12 months, operating cash flow was -19.03T and capital expenditures -4.00, giving a free cash flow of -19.03T billion.
Operating Cash Flow-19.03T
Free Cash Flow-19.03T
Free Cash Flow per Share-2.53M
Dividends & Yields
BioVie pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.92
52-Week Price Change-93.77%
50-Day Moving Average4.98
200-Day Moving Average13.00
Relative Strength Index (RSI)30.94
Average Volume (3m)380.70K
Important Dates
BioVie upcoming earnings date is May 13, 2024, After Close (Confirmed).
Last Earnings DateFeb 14, 2024
Next Earnings DateMay 13, 2024
Ex-Dividend Date―
Financial Position
BioVie as a current ratio of 9.10, with Debt / Equity ratio of 1.84%
Current Ratio9.10
Quick Ratio9.10
Debt to Market Cap25.60
Net Debt to EBITDA0.95
Interest Coverage Ratio-54.30
Taxes
In the past 12 months, BioVie has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioVie EV to EBITDA ratio is 0.95, with an EV/FCF ratio of 0.90.
EV to Sales0.00
EV to EBITDA0.95
EV to Free Cash Flow0.90
EV to Operating Cash Flow0.90
Balance Sheet
BioVie has $17.54T in cash and marketable securities with $349.89B in debt, giving a net cash position of -$17.19T billion.
Cash & Marketable Securities$17.54T
Total Debt$349.89B
Net Cash-$17.19T
Net Cash Per Share-$2.28M
Tangible Book Value Per Share$12.51K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioVie is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside566.67% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast81.20%